Stemtech (STEK) EBIAT (2020 - 2025)
Stemtech (STEK) has disclosed EBIAT for 6 consecutive years, with -$809406.0 as the latest value for Q3 2025.
- Quarterly EBIAT rose 30.9% to -$809406.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Sep 2025, up 43.6% year-over-year, with the annual reading at -$3.8 million for FY2024, 30.58% up from the prior year.
- EBIAT hit -$809406.0 in Q3 2025 for Stemtech, down from -$296280.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of $17.4 million in Q3 2022 to a low of -$24.9 million in Q2 2022.
- Historically, EBIAT has averaged -$1.4 million across 5 years, with a median of -$809406.0 in 2025.
- Biggest YoY gain for EBIAT was 426.83% in 2022; the steepest drop was 3126.53% in 2022.
- Year by year, EBIAT stood at -$848155.0 in 2021, then surged by 46.49% to -$453827.0 in 2022, then crashed by 310.9% to -$1.9 million in 2023, then skyrocketed by 78.9% to -$393445.0 in 2024, then plummeted by 105.72% to -$809406.0 in 2025.
- Business Quant data shows EBIAT for STEK at -$809406.0 in Q3 2025, -$296280.0 in Q2 2025, and -$1.5 million in Q1 2025.